MANUEL DIAZ

CORAL GABLES, FL NPI 1689659062

General Payments — all program years on this page

$7,848.97

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 128
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,557.88 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,557.8821

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,773.8541
2019 $1,406.8930
2020 $281.354
2021 $1,345.9412
2022 $797.5810
2023 $685.4810
2024 $1,557.8821

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077983758 Janssen Pharmaceuticals, Inc $26.52 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086948895 Novartis Pharmaceuticals Corporation $20.85 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086948913 Novartis Pharmaceuticals Corporation $29.76 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110531021 AstraZeneca Pharmaceuticals LP $121.87 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110535536 AstraZeneca Pharmaceuticals LP $116.58 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110538659 AstraZeneca Pharmaceuticals LP $127.64 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110541007 AstraZeneca Pharmaceuticals LP $114.67 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110543693 AstraZeneca Pharmaceuticals LP $29.71 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110545693 AstraZeneca Pharmaceuticals LP $121.87 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110549866 AstraZeneca Pharmaceuticals LP $19.01 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110555268 AstraZeneca Pharmaceuticals LP $124.99 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112816753 ViiV Healthcare Company $121.84 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113465551 Kowa Pharmaceuticals America, Inc. $18.02 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116877072 Medtronic, Inc. $164.23 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116877074 Medtronic, Inc. $18.00 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131038749 PFIZER INC. $20.00 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131058489 PFIZER INC. $23.28 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133735587 Gilead Sciences, Inc. $121.84 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135141831 Lilly USA, LLC $16.00 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154336274 Shionogi Inc $98.84 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154336330 Shionogi Inc $102.36 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.